Vimta Labs Ltd.
Sector: Healthcare
Industry Group: Healthcare Services
537.95-14.8 (-2.67%)
8 Jul, 12:00 AM
Analyst Ratings and Targets
Vimta Labs Ltd. analyst ratings, buy/sell/hold recommendations and 12-month price targets from leading brokerages.
Analyst Ratings
Total recommendations
1
Analysts with Strong Buy
0
Analysts with buy
1
100.0%
100% of analysts have buy or strong buy on this stock implying positive street outlook.
Analysts with Strong Buy
0
Analysts with buy
1
Analysts with hold
0
Analysts with Sell
0
Analysts with Strong Sell
0
Target Price
Current market price
₹ 537.95
Median target price
₹ 743.00 (38.12%)
Highest target price
₹ 743.00 (38.12%)
Average target price
₹ 743.00 (38.12%)
Lowest target price
₹ 743.00 (38.12%)
Financial Estimates
Vimta Labs Ltd. analyst consensus estimates for revenue, EBITDA, PAT and EPS (consolidated) for the next 2 financial years on a rolling basis.
EPS for FY Mar 26: ₹ 17.56 /share
Estimated EPS for FY Mar 27
Median
₹ 20.10(14.46 %)
High
₹ 20.10(14.46 %)
Mean
₹ 20.10(14.46 %)
Low
₹ 20.10(14.46 %)
BPS for FY Mar 26: ₹ 102.28 /share
Estimated BPS for FY Mar 27
Median
₹ 113.40(10.87 %)
High
₹ 113.40(10.87 %)
Mean
₹ 113.40(10.87 %)
Low
₹ 113.40(10.87 %)
Sales for FY Mar 26: ₹ 406.12 Cr
Estimated Sales for FY Mar 27
Median
₹ 470.80 Cr(15.93 %)
High
₹ 470.80 Cr(15.93 %)
Mean
₹ 470.80 Cr(15.93 %)
Low
₹ 470.80 Cr(15.93 %)
Estimates Revision
How Vimta Labs Ltd. analyst consensus for revenue and earnings has been revised over the last 12 months.
EPS revisions in the last 12 months
EPS estimate for FY end:
Mar 2027
Frequently Asked Questions
What is the analyst consensus recommendation for Vimta Labs Ltd.?
The analyst consensus for Vimta Labs Ltd. is Buy. Out of 1 analysts covering the stock, 1 have a Buy or Strong Buy rating (100%), 0 have a Hold and 0 have a Sell or Strong Sell rating.
What is the target price for Vimta Labs Ltd.?
The median analyst target price for Vimta Labs Ltd. is ₹ 743.00, with a high target of ₹ 743.00 and a low target of ₹ 743.00. The mean (average) target is ₹ 743.00.
How many analysts cover Vimta Labs Ltd.?
1 analysts actively cover Vimta Labs Ltd.: 0 Strong Buy, 1 Buy, 0 Hold, 0 Sell and 0 Strong Sell.
What is the upside or downside potential for Vimta Labs Ltd. from the current price?
Based on the current market price of ₹ 537.95 and the median analyst target of ₹ 743.00, there is a 38.1% upside potential for Vimta Labs Ltd. according to analyst consensus.
What is the revenue estimate for Vimta Labs Ltd. for the next financial year?
Analyst consensus estimates Vimta Labs Ltd.'s revenue for FY 2027 at ₹ 470.80 Cr (+15.9% growth), with analyst estimates ranging from ₹ 470.80 Cr (low) to ₹ 470.80 Cr (high). Full revenue and earnings estimates are in the Financial Estimates section.
What is the EPS estimate for Vimta Labs Ltd.?
The current trailing twelve month EPS of Vimta Labs Ltd. is 17.20. Analyst consensus estimates EPS for FY 2027 at ₹ 20.10 per share (+14.5% growth). Forward EPS estimates are in the Financial Estimates section.
What is the BPS estimate for Vimta Labs Ltd.?
Analyst consensus estimates the Book Value Per Share (BPS) of Vimta Labs Ltd. for FY 2027 at ₹ 113.40 per share (+10.9% growth). BPS reflects the net asset value attributable to each share and is used to assess the stock's price-to-book valuation. Forward BPS estimates are in the Financial Estimates section.
Are analysts bullish or bearish on Vimta Labs Ltd.?
Analyst sentiment on Vimta Labs Ltd. leans buy: 100% of analysts have a Buy or Strong Buy rating. The consensus outlook is updated as brokerages revise their ratings — see the Estimates Revision section for how views have shifted.
Has the analyst consensus for Vimta Labs Ltd. been revised recently?
Estimate revision history for Vimta Labs Ltd. is available in the Estimates Revision section of the Forecast tab, showing how analyst consensus for revenue and earnings has changed over the past 12 months.
What is the current PE ratio of Vimta Labs Ltd. compared to the target implied PE?
The current trailing PE of Vimta Labs Ltd. is 31.01. Based on the median analyst target price of ₹ 743.00 and TTM EPS of 17.20, the target-implied forward PE is approximately 43.2x.